Drupal.behaviors.print = function(context) {window.print();window.close();}>
Quark, Nitto Denko Collaborate on RNAi Drugs for Fibrotic Disease
July 15, 2010
Quark, Nitto Denko Collaborate on RNAi Drugs for Fibrotic Disease
The partnership is expected to yield its first IND by 2012.
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Quark Sees Nitto Denko Deal as 'Harbinger' of Future Partnerships
August 5, 2010 / Gene Silencing News
Snapshot: Partnership Goals, Track Records in the RNAi/miRNA Space
July 22, 2010 / Gene Silencing News
Undisclosed Pharma to Evaluate Silence siRNA-Delivery Technology
September 29, 2011 / Gene Silencing News
Sirnaomics Inks Ocular Disease Drug Deal with Chinese Drugmaker
June 30, 2011 / Gene Silencing News
Amid Delivery Tech Dispute, Alnylam Forges Collaboration with Precision NanoSystems
April 21, 2011 / Gene Silencing News